FRANKFURT--The following is a summary of analysts' forecasts for
Sanofi SA (SNY) first-quarter results, based on a poll of seven
analysts conducted by Dow Jones Newswires (figures in million
euros, EPS, dividend and target price in euro, according to IFRS).
Earnings figures are scheduled to be released April 29.
===
Net Business Business Business
1st Quarter sales Oper. Income net income EPS
AVERAGE 8,023 2,251 1,583 1.20
Prev. Year 8,059 2,344 1,613 1.22
+/- in % -0.4 -4.0 -1.9 -1.8
MEDIAN 7,998 2,226 1,585 1.20
Maximum 8,175 2,334 1,613 1.22
Minimum 7,866 2,205 1,551 1.18
Amount 7 7 7 7
Barclays 8,113 2,334 1,613 1.22
Bernstein 8,026 2,305 1,603 1.21
CM-CIC Sec. 7,998 2,216 1,597 1.21
Credit Suisse 7,998 2,205 1,551 1.18
Deutsche Bank 7,866 2,226 1,557 1.18
Helvea 7,985 2,252 1,574 1.19
J.P. Morgan 8,175 2,221 1,585 1.20
Target price Rating DPS 2014
AVERAGE 85.25 positive 3 AVERAGE 2.83
Prev. Quarter 83.07 neutral 2 Prev. Year 2.80
+/- in % +2.6 negative 0 +/- in % +1.0
MEDIAN 83.50 MEDIAN 2.89
Maximum 95.00 Maximum 2.95
Minimum 79.00 Minimum 2.64
Amount 4 Amount 3
Barclays 95.00 Overweight 2.89
Credit Suisse 80.00 Neutral 2.64
Deutsche Bank 87.00 Buy 2.95
Helvea 79.00 Buy --
J.P. Morgan -- Neutral --
===
Year-earlier figures are as reported by the company.
DJG/err
Subscribe to WSJ: http://online.wsj.com?mod=djnwires